# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Natsume Sōseki (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET023-SYN-TD
- Date: 1910-05-21
- Fictional facility: St. Posthumous Health Center
- Fictional author: Haruka Lindqvist-Mori, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Three-day review, with upper endoscopy by gastroenterology this morning. **S**

## History of present illness

Mr. Natsume returns three days after his first visit and had an upper endoscopy this morning with Dr. Abrahamsen-Ito of gastroenterology. Since his first visit he has stopped ibuprofen and taken acetaminophen twice for headache. The epigastric pain continues, gnawing before meals and waking him at night, and is eased by food. His stools have been brown, with no further black stools since ten days before his first visit, and he has not vomited blood or felt faint. He fasted for the endoscopy and has recovered from the sedation. **S**

| Element | Detail |
|---|---|
| Symptoms | Epigastric pain unchanged; no further black stools; no vomiting or fainting |
| Medicines | Ibuprofen stopped; acetaminophen twice |
| Testing today | Upper endoscopy with biopsies and a rapid urease test; hemoglobin |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; no fever or weight loss |
| Gastrointestinal | Positive | Epigastric pain before meals and at night; brown stools; no vomiting |
| Cardiovascular | Negative | No lightheadedness or fainting |
| Psychiatric | Positive | Worried about cancer; no low mood or thoughts of self-harm |

4 systems reviewed. **S**

## Current medications

- Acetaminophen 500 mg oral tablet, one or two tablets by mouth every six hours as needed for headache or pain, no more than 3 g a day (in place of ibuprofen) **S**
- Vonoprazan 20 mg oral tablet, one tablet by mouth each morning for eight weeks for gastric ulcer healing **S**
- Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other day **S**

## Allergies

- No known allergy **S**

## Objective

BP 122/76 mmHg; pulse 82 bpm; respirations 14/min; temperature 36.5 °C; oxygen saturation 98% on room air; weight 51.8 kg; BMI 20.5 kg/m². All vital signs are synthetic.

Hemoglobin: 11 g/dL (low). All results are synthetic.

## Change since baseline

- Hemoglobin: 11.2 g/dL (low) at baseline, 11 g/dL (low) at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Alert after light sedation; pale; weight 51.8 kg; pulse 82, blood pressure 122/76 |
| Abdomen | Mild epigastric tenderness; no guarding, mass or enlarged liver |
| Rectal | Deferred; stools brown by history and at endoscopy no fresh blood in the stomach |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Gastric ulcer with recent bleeding** (K25.4). Endoscopy shows a 15 mm ulcer on the lesser curvature at the angulus with a clean white base (Forrest III), regular margins and smooth converging folds, which look benign; there is no blood in the stomach and the duodenum is normal. A clean base carries a low risk of rebleeding, and with a stable hemoglobin of 11.0 g/dL and normal pulse and blood pressure he can be treated at home. Six biopsies of the ulcer margin were taken because a gastric ulcer can hide a cancer, which is common in Japan. Dr. Abrahamsen-Ito and I agree the plan. **S**
   - Vonoprazan 20 mg each morning for eight weeks, started after the biopsies.
   - No NSAIDs; acetaminophen for pain.
   - Call 119 for black, tarry stools, vomiting blood or coffee-ground material, or fainting.
   - Biopsy results and the eradication plan at two weeks.
2. **Helicobacter pylori infection** (B96.81). The rapid urease test on an antral biopsy is positive. The background mucosa shows open-type atrophy with antral nodularity. Mapping biopsies for histology and a PCR test for clarithromycin resistance were sent; in Japan clarithromycin resistance is common, so treatment will be chosen when the result is back. **S**
   - Eradication therapy at the two-week visit, chosen by the resistance result.
3. **Iron-deficiency anemia** (D50.0). Hemoglobin 11.0 g/dL, stable; the ulcer explains the blood loss. **S**
   - Ferrous sulfate 325 mg every other morning from today, now that the source has been seen.
   - Iron turns the stools dark grey-green or black but formed; black, sticky, tarry stools are different and mean bleeding.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Imaging | Upper endoscopy with biopsy of the ulcer margin | At diagnosis; repeat for a gastric ulcer at 8 to 12 weeks to confirm healing and biopsy the scar | Completed today | 15 mm clean-based gastric ulcer at the angulus (Forrest III); six margin biopsies sent |
| Laboratory | Helicobacter pylori test (rapid urease test and histology) with clarithromycin-resistance testing | At diagnosis, before any acid suppression or antibiotic | Completed today | Rapid urease test positive; histology and clarithromycin-resistance PCR sent |
| Laboratory | Hemoglobin before endoscopy | At endoscopy for a recent bleed | Completed today | 11.0 g/dL, stable from 11.2 |
| Medication safety | Acid suppression for ulcer healing (vonoprazan) | Daily for eight weeks for a gastric ulcer | Completed today | Vonoprazan 20 mg each morning started after the biopsies |
| Medication safety | NSAID avoidance | Every visit | Completed today | Ibuprofen stopped at the first visit; none since |
| Self-management | Bleeding warning signs and when to call 119 | Every visit | Completed today | No new black stools; warning signs and 119 reviewed |
| Self-management | Alcohol, smoking and meals | Every visit | Completed today | Does not smoke; alcohol rarely; regular meals advised |
| Medication safety | Oral iron | From the day the source is found | Completed today | Ferrous sulfate every other morning started today |
| Survey | Stress and depression: PHQ-9 and GAD-7 | At intake and at the end of the episode | Up to date | PHQ-9 7 and GAD-7 8 three days ago |
| Referral | Gastroenterology consultation and endoscopy | Within three days for a recent ulcer bleed | Completed today | Seen by Dr. Abrahamsen-Ito this morning |

## Goal progress

- Endoscopy within three days of the first visit, with cancer excluded by biopsy. In progress; target 1910-06-04. **S**
- No further bleeding and no emergency admission through the episode. In progress; target 1910-08-03. **S**
- Helicobacter pylori eradicated, confirmed by urea breath test. In progress; target 1910-08-03. **S**
- Gastric ulcer healed at repeat endoscopy. In progress; target 1910-08-03. **S**
- Hemoglobin normal and ferritin above 50 ng/mL. In progress; target 1910-08-03. **S**

## Medication changes

- Started: Vonoprazan 20 mg oral tablet, one tablet by mouth each morning for eight weeks for gastric ulcer healing **S**
- Started: Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other day **S**

## Guideline basis

- ACG Clinical Guideline: Treatment of Helicobacter pylori Infection (2024), American College of Gastroenterology (Am J Gastroenterol 2024;119(9):1730-1753)
- Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report (2022), European Helicobacter and Microbiota Study Group (Gut 2022;71(9):1724-1762)
- Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition (2016 (published 2019)), Japanese Society for Helicobacter Research (Helicobacter 2019;24(4):e12597)
- Evidence-based clinical practice guidelines for peptic ulcer disease 2026 (2026), Japanese Society of Gastroenterology (J Gastroenterol 2026;61(10):1361-1381)
- ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding (2021), American College of Gastroenterology (Am J Gastroenterol 2021;116(5):899-917)
- CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026), Aether Forge

## Follow-up

- Two-week visit with the biopsy results, the resistance result, the eradication plan and a hemoglobin. Call 119 for black, tarry stools, vomiting blood or fainting. **S**
- Next scheduled visit 1910-06-04: two-week review: biopsy results, Helicobacter pylori resistance testing, and start of eradication therapy. **S**
